626 related articles for article (PubMed ID: 16585195)
21. Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth.
Erez N; Milyavsky M; Eilam R; Shats I; Goldfinger N; Rotter V
Cancer Res; 2003 Dec; 63(24):8777-83. PubMed ID: 14695194
[TBL] [Abstract][Full Text] [Related]
22. Characterization of ankyrin repeat-containing proteins as substrates of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible transcription factor.
Linke S; Hampton-Smith RJ; Peet DJ
Methods Enzymol; 2007; 435():61-85. PubMed ID: 17998049
[TBL] [Abstract][Full Text] [Related]
23. Prolyl hydroxylase domain enzyme 2 is the major player in regulating hypoxic responses in rheumatoid arthritis.
Muz B; Larsen H; Madden L; Kiriakidis S; Paleolog EM
Arthritis Rheum; 2012 Sep; 64(9):2856-67. PubMed ID: 22488178
[TBL] [Abstract][Full Text] [Related]
24. Oxygen sensing by the prolyl-4-hydroxylase PHD2 within the nuclear compartment and the influence of compartmentalisation on HIF-1 signalling.
Pientka FK; Hu J; Schindler SG; Brix B; Thiel A; Jöhren O; Fandrey J; Berchner-Pfannschmidt U; Depping R
J Cell Sci; 2012 Nov; 125(Pt 21):5168-76. PubMed ID: 22946054
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional activation of hypoxia-inducible factor-1alpha by HDAC4 and HDAC5 involves differential recruitment of p300 and FIH-1.
Seo HW; Kim EJ; Na H; Lee MO
FEBS Lett; 2009 Jan; 583(1):55-60. PubMed ID: 19071119
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of a prolyl hydroxylase domain (PHD) by substrate analog peptides.
Kwon HS; Choi YK; Kim JW; Park YK; Yang EG; Ahn DR
Bioorg Med Chem Lett; 2011 Jul; 21(14):4325-8. PubMed ID: 21665470
[TBL] [Abstract][Full Text] [Related]
27. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases.
Koivunen P; Hirsilä M; Günzler V; Kivirikko KI; Myllyharju J
J Biol Chem; 2004 Mar; 279(11):9899-904. PubMed ID: 14701857
[TBL] [Abstract][Full Text] [Related]
28. Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway.
Giatromanolaki A; Koukourakis MI; Pezzella F; Turley H; Sivridis E; Bouros D; Bougioukas G; Harris AL; Gatter KC
Cancer Lett; 2008 Apr; 262(1):87-93. PubMed ID: 18187257
[TBL] [Abstract][Full Text] [Related]
29. Nutlin-3, an Hdm2 antagonist, inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated inactivation of HIF-1alpha.
Lee YM; Lim JH; Chun YS; Moon HE; Lee MK; Huang LE; Park JW
Carcinogenesis; 2009 Oct; 30(10):1768-75. PubMed ID: 19696166
[TBL] [Abstract][Full Text] [Related]
30. The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability.
Barth S; Nesper J; Hasgall PA; Wirthner R; Nytko KJ; Edlich F; Katschinski DM; Stiehl DP; Wenger RH; Camenisch G
Mol Cell Biol; 2007 May; 27(10):3758-68. PubMed ID: 17353276
[TBL] [Abstract][Full Text] [Related]
31. MYPT1, the targeting subunit of smooth-muscle myosin phosphatase, is a substrate for the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH).
Webb JD; Murányi A; Pugh CW; Ratcliffe PJ; Coleman ML
Biochem J; 2009 May; 420(2):327-33. PubMed ID: 19245366
[TBL] [Abstract][Full Text] [Related]
32. Identification of residues critical for regulation of protein stability and the transactivation function of the hypoxia-inducible factor-1alpha by the von Hippel-Lindau tumor suppressor gene product.
Pereira T; Zheng X; Ruas JL; Tanimoto K; Poellinger L
J Biol Chem; 2003 Feb; 278(9):6816-23. PubMed ID: 12468553
[TBL] [Abstract][Full Text] [Related]
33. Molecular evolution of the metazoan PHD-HIF oxygen-sensing system.
Rytkönen KT; Williams TA; Renshaw GM; Primmer CR; Nikinmaa M
Mol Biol Evol; 2011 Jun; 28(6):1913-26. PubMed ID: 21228399
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide donor, (+/-)-S-nitroso-N-acetylpenicillamine, stabilizes transactive hypoxia-inducible factor-1alpha by inhibiting von Hippel-Lindau recruitment and asparagine hydroxylation.
Park YK; Ahn DR; Oh M; Lee T; Yang EG; Son M; Park H
Mol Pharmacol; 2008 Jul; 74(1):236-45. PubMed ID: 18426857
[TBL] [Abstract][Full Text] [Related]
35. Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma.
Kumar SM; Yu H; Edwards R; Chen L; Kazianis S; Brafford P; Acs G; Herlyn M; Xu X
Cancer Res; 2007 Apr; 67(7):3177-84. PubMed ID: 17409425
[TBL] [Abstract][Full Text] [Related]
36. Differences in hydroxylation and binding of Notch and HIF-1alpha demonstrate substrate selectivity for factor inhibiting HIF-1 (FIH-1).
Wilkins SE; Hyvärinen J; Chicher J; Gorman JJ; Peet DJ; Bilton RL; Koivunen P
Int J Biochem Cell Biol; 2009 Jul; 41(7):1563-71. PubMed ID: 19401150
[TBL] [Abstract][Full Text] [Related]
37. [The expression of hypoxia-inducible factor-1alpha and its hydroxylases in pulmonary arteries of patient with chronic obstructive pulmonary disease].
Chen YR; Dai AG; Hu RC; Kong CC
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 May; 28(3):234-8. PubMed ID: 22860423
[TBL] [Abstract][Full Text] [Related]
38. Oxygen-sensing under the influence of nitric oxide.
Berchner-Pfannschmidt U; Tug S; Kirsch M; Fandrey J
Cell Signal; 2010 Mar; 22(3):349-56. PubMed ID: 19861159
[TBL] [Abstract][Full Text] [Related]
39. Leu-574 of human HIF-1alpha is a molecular determinant of prolyl hydroxylation.
Kageyama Y; Koshiji M; To KK; Tian YM; Ratcliffe PJ; Huang LE
FASEB J; 2004 Jun; 18(9):1028-30. PubMed ID: 15084514
[TBL] [Abstract][Full Text] [Related]
40. Role of reactive oxygen species in the regulation of HIF-1 by prolyl hydroxylase 2 under mild hypoxia.
Niecknig H; Tug S; Reyes BD; Kirsch M; Fandrey J; Berchner-Pfannschmidt U
Free Radic Res; 2012 Jun; 46(6):705-17. PubMed ID: 22360728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]